June 2024 Provider Newsletter

Contents

AdministrativeMedicaidJune 1, 2024

Reminder: Balance billing prohibited

AdministrativeCommercialMedicare AdvantageMedicaidJune 1, 2024

Availity Essentials single claim submission response reports

AdministrativeCommercialMedicaidMarch 4, 2024

Access to care standards

AdministrativeCommercialMedicaidMay 16, 2024

Health Equity and Quality Measure Set reporting

AdministrativeCommercialJune 1, 2024

CAA: Review your online provider directory information

Digital SolutionsCommercialMedicare AdvantageMedicaidMay 23, 2024

Digital RFAI Availity training

Digital SolutionsMedicare AdvantageApril 24, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

Education & TrainingCommercialMedicare AdvantageMedicaidJune 1, 2024

June is LGBTQIA+ Pride Month

Education & TrainingCommercialMedicare AdvantageMedicaidMay 21, 2024

You are invited: Thriving, not just surviving: navigating challenging times as a clinician

Education & TrainingCommercialMedicare AdvantageMedicaidJune 1, 2024

Introducing advanced eLearning features for MyDiversePatients.com

Policy UpdatesMedicare AdvantageMay 10, 2024

Carelon Medical Benefits Management, Inc updates

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 2, 2024

Carelon Medical Benefits Management, Inc. genetic testing code updates

Medical Policy & Clinical GuidelinesMedicaidMay 13, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Medical Policy & Clinical GuidelinesMedicare AdvantageApril 26, 2024

MCG Care Guidelines 28th edition

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 7, 2024

Clinical Criteria updates

PharmacyMedicare AdvantageJune 1, 2024

Addressing medication adherence gaps

PharmacyCommercialJune 1, 2024

Pharmacy information available on our provider website

PharmacyMedicare AdvantageJune 1, 2024

Improving patient outcomes with statin therapy in diabetes

Quality ManagementCommercialMay 6, 2024

Enhance patient access to digital health resources

Quality ManagementMedicaidJune 1, 2024

Important information about utilization management

Quality ManagementMedicaidJune 1, 2024

Members’ Rights and Responsibilities section

Quality ManagementMedicaidJune 1, 2024

Complex Case Management program

Quality ManagementCommercialApril 19, 2024

Improving patient health and digital literacies

Quality ManagementCommercialMedicaidApril 23, 2024

Tips to Improve Adolescent Immunization (IMA) Rates

Quality ManagementCommercialMedicare AdvantageMedicaidJune 1, 2024

New resources to improve your HEDIS® and CAHPS® quality rates

CABC-CDCRCM-059350-24

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

AdministrativeMedicaidJune 1, 2024

Reminder: Balance billing prohibited

Balance billing Medi-Cal Managed Care (Medi-Cal) beneficiaries is prohibited by federal and state law. 

Medi-Cal beneficiaries should not pay for physician visits and other medical care when they receive covered services from a provider in their provider network. This means beneficiaries cannot be charged for co-pays, co-insurance, or deductibles. This applies to both Medicare and Medi-Cal providers.

Billing Medi-Cal beneficiaries violates federal law as outlined in section 1902(n)(3)(B) of the Social Security Act, as modified by section 4714 of the Balanced Budget Act of 1997. This section of the act is available at: http://www.ssa.gov/OP_Home/ssact/title19/1902.htm. Protections are also found in California Welfare and Institutions Code section 14019.4.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-012346-22, CABC-CD-060248-24

AdministrativeCommercialMedicare AdvantageMedicaidJune 1, 2024

Availity Essentials single claim submission response reports

Does your organization submit single claim submissions online to Availity Essentials? This feature is a no-cost option to submit your claims, but like all claim submissions, it’s important to review the response reports to ensure your claim has been accepted.

How do I view my response reports?

Your organization’s Availity administrator will need to assign the electronic data interchange (EDI) management role to users who submit online claim submissions. Even though the claims are submitted without using EDI software or a vendor, online claim submissions are still considered EDI transactions that will create response reports.

Once the role has been assigned, the user will have access to the EDI clearinghouse menu located under the Claims & Payments menu. The three tiles used are listed below:

  • Send and receive EDI files — The response files will be in the receive folder.
  • File restore — Availity will archive your response files after 60 days; use this option to restore your reports.
  • EDI reporting preferences — Select text > Human readable format. The other formats are only used for EDI software.

What kind of response reports do I need to view?

  • File acknowledgments — shows your claim has been received
  • Immediate batch response — acknowledges accepted claim and identifies if rejected due to HIPAA and/or payer-specific edits
  • Delayed payer reports — Certain policies will go through a second level of editing for the payer; This report will return if that is the case.

We are here to help

Availity Essentials offers on-demand recorded training and documentation to assist with reviewing your response reports:

  • Log in to Availity Essentials and select Help & Training > Get Trained.
  • Use the catalog filter and select EDI Clearinghouse; several courses will display for you to enroll in and view.
  • Use the EDI Companion Document to view the Setup EDI Reporting Preferences Chapter.
  • Contact Availity Client Services at 800-282-4548 Monday through Friday from 8 a.m. until 8 p.m.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCRCM-057150-24-CPN54585

AdministrativeCommercialMedicaidMarch 4, 2024

Access to care standards

Participating providers are responsible for offering members access to covered services 24/7. Access includes regular office hours on weekdays and the availability of a provider or designated agent by telephone after regular office hours, on weekends, and on holidays. When unavailable, providers must arrange for on-call coverage by another participating provider. Providers are also required to meet appointment access standards as described below.

After-hours calls:

  • Providers must instruct their after-hours answering service to answer Anthem’s After Hours Survey questions. Non-compliant providers are subject to contractual enforcement actions, such as Corrective Action Plans (CAP) or escalated contractual sanctions for breach of contract.
  • The answering service or after-hours personnel must ask the member if the call is an emergency. In the event of an emergency, the member must be immediately directed to dial 911 or to proceed directly to the nearest hospital emergency room.
  • If staff or answering service is not immediately available, an answering machine may be used. The answering machine message must instruct members with emergency healthcare needs to dial 911 or go directly to the nearest hospital emergency room. The message must also give members an alternative contact number so they can reach the primary care physician (PCP) or on-call provider with medical concerns or questions.
  • Non-English-speaking members who call their PCP after hours should expect to get
    language-appropriate messages. In the event of an emergency, these messages should direct the member to dial 911 or proceed directly to the nearest hospital emergency room.
  • In a non-emergency situation, members should receive instruction on how to contact the on-call provider. If an answering service is used, the service should know where to contact a telephone interpreter. All calls taken by an answering service must be returned.

Appointment access

Note: The next available appointment date and time can be either in-person or by telehealth services.

Healthcare providers must make appointments for members from the time of request as follows:

General appointment scheduling

Emergency examination

Immediate access, 24/7

Urgent (sick) examination

Within 48 business hours of request if authorization is not required or within 96 business hours of request if authorization is required, or as clinically indicated

Routine primary care examination (non‑urgent)

Within 10 business days of request

Non-urgent consults/specialty referrals

Within 15 business days of request

Non-urgent care with non-physician mental health provider or substance use disorder (SUD) provider (where applicable)

Within 10 business days of request

Non-urgent follow-up care with non-physician mental health provider or SUD provider

Within 10 business days of request

Non-urgent ancillary

Within 15 business days of request

Mental health appointment, non-physician

Within 10 business days of request

SB221 — Effective since July 1, 2022, non-physician mental health/SUD appointments are subject to the timely access standards outlined in the chart above. This bill also requires that all health plans ensure that enrollees who are undergoing a course of treatment for an ongoing mental health or SUD condition can schedule a follow up appointment with their non-physicians mental healthcare or SUD provider within 10 business days of the prior appointment.

Services for members under the age of 21 years

Initial health assessments

Children from birth to 20 years of age

Within 120 days of enrollment

Preventive care visits

Within 14 days of request

Services for members 21 years of age and older

Initial health assessments

Within 120 days of enrollment

Preventive care visits

Within 14 days of request

Routine physicals

Within 30 days of request

Prenatal and postpartum visits

First and second trimester

Within seven days of request

Third trimester

Within three days of request

High-risk pregnancy

Within three days of identification

Postpartum

Between 7 and 84 days after delivery

Long-term services and supports

Skilled nursing facility

  • Rural and small counties — within 14 business days of request
  • Medium counties — within seven business days of request
  • Dense counties — within five business days of request

Intermediate care facility/developmentally disabled (ICF-DD)

  • Rural and small counties — within 14 business days of request
  • Medium counties — within seven business days of request
  • Dense counties — within five business days of request

Community-based adult services (CBAS)

Capacity cannot decrease in aggregate statewide below April 2021 level

Specialists

The following guidelines are in place for our specialists:

  • For urgent care, the specialist should see the member within 96 hours of receiving the request.
  • For routine care, the specialist should see the member within 15 business days of receiving the request.
  • A copy of the medical records and/or results of the visit should be sent to the PCP’s office to allow continuity of care.

Wait times

When a provider's office receives a call from an Anthem member during regular business hours — as well as after hours — for assistance and possible triage, the provider or another healthcare professional must either take the call or call the member back within 30 minutes of the initial call.

When an Anthem member arrives on time to an appointment, the member should be seen within 15 minutes of the scheduled appointment.

When Anthem members and/or prospective members call a physician’s office, they should not be placed on hold for longer than 10 minutes.

Interpretation services

When a provider’s office receives a call from an Anthem member, the provider’s office should know where to contact a telephone interpreter to communicate in the member’s preferred language.

Noncompliance

Ensure that you comply with the standards described; compliance with these standards is a contractual requirement. Anthem monitors compliance through a number of mechanisms, including annual telephonic surveys, to determine if participating provider offices meet the above standards.

For additional details, review the provider manuals at
https://providers.anthem.com/california-provider/resources/manuals-policies-guidelines.

Beginning in 2023, delegated network providers will be measured based on a compliance threshold of 70% as outlined in CCR 1300.67.2.2. Delegates scoring below 70% compliance for Non-Urgent and Urgent appointment availability will be subject to corrective action, up to and including, termination of the contract.

Required timely access training course — to be released in measurement year 2024

Rescheduling missed appointments — Los Angeles county providers only

Missed appointments

Standard

The time after a missed appointment that a patient is contacted to reschedule their appointment

48 hours




This is a reminder that Los Angeles county providers are required to call to reschedule an appointment within 48 hours after a missed appointment. Ensure your office’s policies and procedures and training are updated to include this requirement. Providers may be surveyed on a random sample to ensure compliance with this standard.

Schedule of timely access surveys

Provider Appointment Availability Survey (PAAS):

  • Survey subject(s): Appointment availability
  • Managed Care Plan: Anthem
  • Contractor conducting survey: Sutherland
  • Regulatory agency: Department of Managed Health Care (DMHC)
  • Schedule: July through November 2024

After Hours and Appointment Availability Survey:

  • Survey subject(s): Emergency and urgent after-hours calls
  • Managed Care Plan: Anthem
  • Contractor conducting survey: TBD
  • Regulatory agency: National Committee for Quality Assurance (NCQA); DMHC
  • Schedule: October through November 2024

Primary Care and Specialty Care Appointment Availability Survey:

  • Survey subject(s): Appointment availability, interpretation services
  • Conducting/regulatory agency: Department of Health Care Services (DHCS)
  • Schedule:
    • Q1: January through March
    • Q2: April through June
    • Q3: July through September
    • Q4: October through December

DHCS administers the surveys, and Anthem is provided the surveys after each quarter.

Non-compliant providers are subject to contractual enforcement actions, such as Corrective Action Plans (CAP) or escalated contractual sanctions for breach of contract.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCM-050906-24, CABC-CDCM-060259-24, CABC-CDCM-070100-24

AdministrativeCommercialMedicaidMay 16, 2024

Health Equity and Quality Measure Set reporting

Per the Department of Managed Health Care (DMHC) All Plan Letter (APL) 22-028 — Health Equity and Quality Measure Set and Reporting Process, health plans including Anthem are required to meet the Health Equity and Quality Measure Set (HEQMS) and stratification of the HEQMS by race, language, and ethnicity as of January 1, 2023. Health plans are required to report on all HEQMS measures comprised of 12 Healthcare Effectiveness Data and Information Set® (HEDIS) measures and one Consumer Assessment of Healthcare Providers and Systems® (CAHPS) measure. The APL is linked below for your reference.

As a contracted Anthem healthcare provider, your organization is required to submit HEQMS and stratify such information to Anthem according to the APL.

The standardized set of health data elements contracted providers are required to submit must be in the most recent United States Core Data for Interoperability (USCDI) version. Here is a link to the detail list, including required code sets and terminology:

https://healthit.gov/isa/sites/isa/files/2021-07/USCDI-Version-2-July-2021-Final.pdf

We hope that in addition to directly providing this data to Anthem, you will consider joining a qualified health information organization (QHIO) available to providers seeking assistance in meeting the new data connectivity requirements under Assembly Bill 133. Some QHIO examples:

  • Cozeva
  • Health Gorilla, Inc.
  • Long Health, Inc.
  • Los Angeles Network for Enhanced Services (LANES)
  • Manifest MedEx
  • Orange County Partners in Health HIE
  • SacValley MedShare
  • San Diego Health Connect
  • Serving Communities HIO

We invite you to work with such QHIOs not only to meet the requirements described in this communication (obtained from the DMHC All Plan Letter) but also to drive your own success and ensure that you are capturing data to support the high-quality care you deliver. QHIOs can support your work in driving improvements in HEDIS metrics, Medicare Stars, and risk adjustment.

Data exchange via QHIO can assist with:

  • Closing clinical care gaps and improving the quality of patient care.
  • Reducing and/or eliminating the need for traditional medical chart-chase requests for HEDIS, Medicare Stars, and risk adjustment.
  • Improving performance.
  • Complying with DMHC’s regulatory requirements for all California healthcare entities.

Continue to check the Data Exchange Framework CDII (ca.gov) for any updates.

Contact us with questions or concerns: email a provider experience associate.

Reference
APL 22-028 - Health Equity and Quality Measure Set and Reporting Process (12_21_2022).pdf (ca.gov)

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCM-059087-24

AdministrativeCommercialJune 1, 2024

Timely Access Regulations and Language Assistance Program June 2024

2024 PAAS Surveys

Each year, Anthem, along with other health plans in California, conducts Provider Appointment Availability (PAAS) and After-Hours Surveys. These surveys are administered to specific randomly selected network providers. The PAAS Survey assists in evaluating whether members can obtain care provider appointments within time frames mandated by the Department of Managed Health Care (DMHC) and California Department of Insurance (CDI). The After-Hours Survey measures care provider compliance with the standards relating to the availability of emergency and after-hours service.

2024 surveys coming soon

Anthem contracts with a vendor to administer the surveys. Sutherland Healthcare Solutions will conduct the 2024 PAAS and After-Hours Surveys from July through December 31, 2024.

Understanding how to comply

If Sutherland Healthcare Solutions contacts your office (via fax, email, or telephone), a surveyor will ask questions about urgent and non-urgent appointment availability. Refer to the charts that follow for specific standards:

  • Compliant: Care provider offers an appointment within the required appointment time frames.
  • Non-compliant: Care provider fails to offer an appointment within any of the required time frames or refuses to participate in the survey. Non-compliant care providers will receive a letter from Anthem requesting a Corrective Action Plan.
  • Next available appointment date and time can be either in-person or by telehealth services.

Please take a moment to review and share with your staff the following access standards tables for medical and behavioral health professionals.

Access standards for medical professionals and ancillary care providers

Appointment type

Maximum wait time after appointment request

Non-urgent primary care (PCP)

10 business days

Non-urgent specialist physician (SCP)

15 business days

Non-urgent appointment for ancillary services (for diagnosis or treatment of injury, illness, or other health condition)

15 business days

Urgent care (not requiring prior authorization)

48 hours

Urgent care (requires prior authorization) (SCP)Urgent Care (requiring prior authorization)

96 hours

Access standards for behavioral health and EAP care providers

Appointment type

Maximum wait time after appointment request

Non-life-threatening emergency care

  • Six hours
  • Direct members to 911 or nearest emergency room

Urgent care (not requiring prior authorization)

48 hours

Urgent care (requires prior authorization)

96 hours

Routine office visit/non-urgent appointment

  • 10 business days (psychiatrists)*
  • 10 business days (non-physician mental health care providers/substance use disorder)
  • 10 business days from the prior appointment for those undergoing a course of treatment (non-physician mental healthcare/substance use disorder)
  • Five business days (EAP)

* The DMHC timely access standard is 15 business days for psychiatrists. However, to comply with the NCQA accreditation standard of 10 business days, Anthem uses the more stringent standard.

Access standards for after-hours

Emergency care

Anthem expects every care provider to instruct their after-hours answering service staff that if the caller is experiencing an emergency, instruct the caller to dial 911, or to go directly to the emergency room. Answering machine instructions must also direct the member to call 911 or go to the emergency room if the caller is experiencing an emergency.

Direct members to dial 911 or go to the nearest emergency room.

Urgent requests

Available 24/7. Member to reach a recorded message or live voice response providing emergency instructions; and for non-emergent (urgent) matters a mechanism to reach a medical professional, or a practitioner
(non-MD) with information as to when to expect a call back.

  • Only appropriately qualified staff such as a physician, physician assistant, nurse practitioner, or registered nurse are allowed to provide triage or screening clinical advice.
  • Interpreter services are coordinated by Anthem or its delegated network provider or other delegated entity with scheduled appointments for healthcare services in a manner that ensures the provision of interpreter services at the time of the appointment without imposing delay on the scheduling of the appointment. Anthem requires care providers and office staff to document members’ request, acceptance, or refusal of interpreter services in the medical record.
  • Referrals to a specialist by a primary care provider or another specialist must meet applicable timely access standards.

As a reminder, in 2023, the DMHC expanded the list of physician and service type providers included in the PAAS. The table below identifies a current list of care providers included in the PAAS.

Primary care and non-physician mental health care providers

Specialist physicians

Primary care physicians

Cardiovascular disease and pediatric cardiology

Non-physician medical practitioners providing primary care

Dermatology and pediatric dermatology

Non-physician mental health care (NPMH) providers

Endocrinology and pediatric endocrinology

Licensed professional clinical counselor (LPCC)

Gastroenterology and pediatric gastroenterology

Psychologist (PhD level)

Epilepsy, neurology, and pediatric neurology

Marriage and family therapist

Oncology and pediatric hematology/oncology

Licensed marriage and family therapist

Ophthalmology

Master of social work

Otolaryngology and pediatric otolaryngology

Licensed clinical social worker

Pediatric pulmonology and pulmonology

Ancillary service providers that provide appointments to the following services:

Urology and pediatric urology

Mammogram

Psychiatrists, who practice in one or more of the following specialties or subspecialties:

psychiatry (addiction, child, adolescent, geriatric)

Physical therapy

Keeping you informed

According to SB 221, effective January 1, 2023, a referral to a specialist by a primary care provider or another specialist should comply with the required time frame standards.

Why is this important?

Anthem is required by law to obtain appointment availability information from our network providers annually. We must ensure that our provider network can offer members an appointment within specific time frames. There are limits on how long members can wait to receive healthcare appointments and telephone advice.

The DMHC and CDI require that Anthem monitor its provider network and request a Corrective Action Plan if timely access to care standards are not met or if the provider refuses to participate in the survey.

Anthem recognizes that in certain circumstances time-elapsed requirements may not be met. The timely access regulations have provided exceptions to the time-elapsed standards to address these situations:

  • Extending appointment wait time: The applicable waiting time for a particular appointment may be extended if the referring or treating licensed healthcare provider (or the health professional providing triage or screening services, as applicable, acting within the scope of his or her practice and consistent with professionally recognized standards of practice) has determined and noted in the relevant record that a longer waiting time will not have a detrimental impact on the health of the patient.
  • Preventive care services and periodic follow-up care: Preventive care services and periodic follow up care are not subject to the appointment availability standards. These services may be scheduled in advance consistent with professionally recognized standards of practice as determined by the treating licensed health care provider acting within the scope of his or her practice. Periodic follow-up care includes but is not limited to standing referrals to specialists for chronic conditions, periodic office visits to monitor and treat pregnancy, cardiac or mental health conditions, and laboratory and radiological monitoring for recurrence of disease.
  • Advanced access: The primary care appointment availability standard may be met if the primary care physician office provides advanced access. Advanced access means offering an appointment to a patient with a primary care physician (or nurse practitioner or physician’s assistant) within the same or next business day from the time an appointment is requested (or a later date if the patient prefers not to accept the appointment offered within the same or next business day). Note: This exception does not apply to commercial behavioral health.

24/7 NurseLine gives peace of mind

Anthem members can access our 24/7 NurseLine, to get advice from a registered nurse anytime. The toll-free phone number is listed on the back of the member ID card and the wait time cannot exceed 30 minutes.

Help is a phone call away

For general questions or difficulties in obtaining a referral, members and providers can call the toll-free phone number on the back of the member ID card to speak with the Member Services team for Anthem. Representatives are available within 10 minutes during normal business hours.

For patients (members) with DMHC regulated health plans

If you or your patients are unable to obtain a timely referral to an appropriate care provider or for more information about the regulations, visit the DMHC website at dmhc.ca.gov or call toll-free 888-466-2219 for assistance.

For patients (members) with CDI regulated health plans

If you or your patients are unable to obtain a timely referral to an appropriate care provider or for more information about the regulations, visit the CDI website at insurance.ca.gov or call toll-free 800-927-4357 for assistance.

Language assistance program

For members whose primary language is not English, Anthem offers at no cost, language assistance services through interpreters and other written languages. If you or the member is interested in these services, please call the Member Services number listed on the Anthem member ID card for help (TTY/TDD: 711).

Questions

If you have any questions about this communication, contact your assigned provider relationship account manager or visit anthem.com/ca/provider/contact-us to view additional contact information.

We hope this clarifies Anthem’s expectations and your obligations regarding compliance with the timely access regulations. Our goal is to work with you, to successfully meet the expectations for the requirements with the least amount of difficulty and member abrasion. Anthem can only achieve this compliance with the help of our network providers — you!

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CM-058758-24

AdministrativeCommercialJune 1, 2024

CAA: Review your online provider directory information

Please review your online provider directory information on a regular basis to ensure that it’s correct. Access your online provider directory information by visiting anthem.com/ca/provider, then at the top of the webpage, choose Find Care. Review your information and let us know if any of your directory information has changed.

Updating your information

Anthem uses the provider data management (PDM) capability available on Availity Essentials to update your provider or facility data. Using the Availity PDM capability meets the quarterly attestation requirement to validate provider demographic data set by the Consolidated Appropriations Act (CAA).

PDM features include:

  • Updating provider demographic information for all assigned payers in one location.
  • Attesting to and managing current provider demographic information.
  • Monitoring submitted demographic updates in real-time with a digital dashboard.
  • Reviewing the history of previously verified data.

Accessing the PDM application

Log on to Availity.com and select My Providers > Provider Data Management to begin using PDM. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information.

PDM training

PDM training is available:

Not registered for Availity yet?

If you aren’t registered to use Availity Essentials, signing up is easy and 100% secure. There is no cost for providers to register or to use any of our digital applications. Start by going to Availity.com and selecting New to Availity? Get Started at the top of the home screen to access the registration page. If you have more than one tax ID number (TIN), please ensure you have registered all TINs associated with your account.

If you have questions regarding registration, reach out to Availity Client Services at 800-AVAILITY.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CM-058914-24

Digital SolutionsCommercialMedicare AdvantageMedicaidMay 23, 2024

Digital RFAI Availity training

In collaboration with Availity, we’ve developed self-paced training for your organization’s administrators about how to update the Medical Attachment registration.

Care providers enrolled in the Medical Attachments applications on Availity Essentials can now take advantage of faster claims processing through Digital Request for Additional Information (Digital RFAI). Receive digital notifications faster when additional documents are needed to process member claims.

Availity administrators can use this link to view the training on demand for Digital Request for Additional Information: Pre-check for Administrators.

We have also developed an enhanced training session for associates responsible for sending attachments. This training walks through the Attachments Dashboard and many of the unique features that make the dashboard most efficient.

Use thislink to register for the live trainings or to view the training on demand for Learn How to Submit Digital Requests for Additional Information (RFAI).

Register today!

  • June 11, 2024, from 2:30 to 3:30 p.m. ET
  • June 13, 2024, from 2:30 to 3:30 p.m. ET.

We are committed to finding solutions that help our care provider partners offer quality services to our members.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCRCM-057564-24-CPN57402

Digital SolutionsMedicare AdvantageApril 24, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

Effective October 1, 2024, Carelon Medical Benefits Management, Inc. will expand multiple programs to perform medical necessity reviews for additional procedures for Anthem members. Carelon Medical Benefits Management works to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping to promote care that is appropriate, safe, and affordable.

The expansion will require clinical appropriateness review for additional procedures related to Carelon Medical Benefits Management programs, including cardiology, radiation oncology, radiology, musculoskeletal, sleep, surgical, and additional outpatient services.

Carelon Medical Benefits Management will follow the clinical hierarchy established by Anthem for medical necessity determination. Anthem makes coverage determinations based on CMS guidance, including national coverage determinations (NCDs), local coverage determinations (LCDs), other coverage guidelines and instructions issued by CMS, and legislative changes in benefits. When existing guidance does not provide sufficient clinical detail, Carelon Medical Benefits Management will determine medical necessity using an objective, evidence-based process.

Carelon Medical Benefits Management will continue to use criteria documented in the Medical Policies and Clinical Guidelines of Anthem listed in the table below. These clinical guidelines can be found at Availity.com.

Detailed prior authorization (PA) requirements are available online by accessing the Precertification Lookup Tool under Payer Spaces at Availity.com. Contracted and noncontracted care providers should call Provider Services at the phone number on the back of the member’s ID card for PA requirements.

Prior authorization review requirements

Carelon Medical Benefits Management will begin accepting PA requests on September 24, 2024, for dates of service October 1, 2024, and after. For procedures scheduled to begin on or after October 1, 2024, care providers must contact Carelon Medical Benefits Management to obtain PA for the non‑emergency modalities below. Refer to the clinical guidelines on the microsite resource pages for complete code lists.

Program

Services 

Medical Policies or Clinical Guidelines

Cardiovascular

  • OP cardiac hemodynamic monitoring with wireless sensor for heart failure management

  • Non-invasive heart failure and arrhythmia monitoring system

  • Carotid sinus baroreceptor stimulation devices
  • MED.00115
  • SURG.00124
  • MED.00134

Additional outpatient utilization management

  • Therapeutic apharesis

  • Hyperbaric oxygen therapy

  • Physiologic record of tremor

  • Home enteral and parenteral nutrition

  • Ambulance services

  • Virtual reality-assisted therapy systems

  • Home visual field monitor

  • Colonic irrigation

  • Automated evacuation of meibomian gland

  • Prothrombin time
    self-monitoring devices
  • CG-ANC-06
  • CG-DME-30
  • CG-MED-08
  • CG-MED-68
  • CG-MED-73
  • CG-MED-89
  • DME.00048
  • MED.00101
  • MED.00103
  • MED.00131
  • MED.00141

Musculoskeletal

  • Deep brain, cortical, and cerebellar stimulation
  • Implant of nerve stimulation devices
  • Extracorporeal shock wave therapy
  • SURG.00158
  • SURG.00026
  • SURG.00112
  • SURG.00045

Surgical

  • Surgical GI
  • Transendoscopic therapy
  • Surg. Tx of hyperhidrosis
  • Skin-related cosmetic and reconstructive services
  • Tonsilectomy/adenoidectomy
  • Cochlear and auditory brainstem implants
  • Implantable hearing aids
  • Drug-eluting devices to maintain sinus ostial patency
  • Temporomandibular disorders
  • Nasal valve repair
  • Minimally invasive Tx of posterior nasal nerve for rhinitis
  • Gastric electrical stimulation
  • Uterine fibroid ablation
  • Sacral nerve stimulatioon Tx of neurogenic bladder secondary to spinal cord injury
  • Vagus nerve stimulation
  • Ablation for solid tumors outside the liver
  • Intraocular telescope
  • Automated evacuation of meibomian gland
  • Intraocular anterior segment aqueous drainage devices
  • Implanted artificial iris devices
  • Implantable infusion pumps
  • Tx for urinary and fecal incontinence
  • Panniculectomy and abdominoplasty
  • Regenerative cell therapy and soft tissue augmentation
  • Products for wound healing and soft tissue grafting
  • Surgical and ablative Tx for chronic headaches
  • Intraoperative assessment of surgical margins during breast-conserving surgery
  • Mandibular/maxillary surgery
  • Penile prosthesis implantation
  • Diaphragmatic/phrenic nerve Stimulation and pacing systems
  • Radiofrequency ablation of renal sympathetic nerves
  • Synthetic cartilage implant for metatarsophalangeal joint disorders
  • Surgical Tx for OSA
  • Percutaneous vertebral disc/endplate procs.
  • ANC.00007
  • CG-MED-79
  • CG-SURG-08
  • CG-SURG-09
  • CG-SURG-116
  • CG-SURG-12
  • CG-SURG-30
  • CG-SURG-36
  • CG-SURG-61
  • CG-SURG-70
  • CG-SURG-79
  • CG-SURG-81
  • CG-SURG-82
  • CG-SURG-84
  • CG-SURG-95
  • CG-SURG-96
  • CG-SURG-99
  • MED.00103
  • MED.00132
  • SURG.00007
  • SURG.00010
  • SURG.00011
  • SURG.00077
  • SURG.00079
  • SURG.00096
  • SURG.00103
  • SURG.00129
  • SURG.00132
  • SURG.00135
  • SURG.00139
  • SURG.00147
  • SURG.00156
  • SURG.00157
  • SURG.00052

Sleep

  • Electronic positional devices for Tx of OSA
  • Surgical Tx for OSA
  • Implantable nerve stim.
  • Respiratory assist device
  • SURG.00129
  • DME.00042
  • SURG.00007
  • CMS Criteria
  • CG-SURG-95

To determine if PA is needed for a member on or after October 1, 2024, call Provider Services using the phone number on the back of the member’s ID card. Care providers using the interactive care reviewer (ICR) tool on Availity.com for PA requests on an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management (Note: ICR cannot accept PA requests for services administered by Carelon Medical Benefits Management).

How to place a review request

Care providers may place a PA request online to Carelon Medical Benefits Management by way of providerportal.com. ProviderPortalSM is available 24/7, processing requests in real-time using clinical criteria.

For more information

For resources to help your practice get started with the cardiology, musculoskeletal, surgical, and programs, visit:

Our website helps you access information and tools such as order entry checklists, Clinical Guidelines, and FAQs.

Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CR-056609-24-CPN56138

Education & TrainingCommercialMedicare AdvantageMedicaidJune 1, 2024

June is LGBTQIA+ Pride Month

We strive to advance health equity so everyone has a fair opportunity to be at their healthiest. As we reduce barriers to whole health — physical, behavioral, and social — and personalize the healthcare journey, we can more effectively advance health equity. While focusing on understanding member needs, we actively develop educational tools for providers.

In recognition of June as National LGBTQIA+ Pride Month, we are introducing three eLearning tools on LGBTQIA+ health, available on the My Diverse Patients site. This site offers a comprehensive repository of resources for providers to help support the needs of diverse patients and address healthcare disparities. Multiple free continuing medical education (CME) courses are available, with CME credits offered through the American Academy of Family Physicians (AAFP).

For the month of June, our featured eLearning experience and resources are:

  • My Inclusive Practice — Improving Care for LGBTQIA+ Patients — a CME credit hour provider training. Course benefits:
    • Understand the fears and anxieties LGBTQIA+ patients often feel about seeking medical care.
    • Learn key health concerns of LGBTQIA+ patients.
    • Develop strategies for providing effective healthcare to LGBTQIA+ patients.
    • Review ideas for creating a welcoming office environment.
  • National LGBTQIA+ Health Education Center — Resources & Tools:
    • The National LGBTQIA+ Health Education Center provides educational programs, resources, and consultation to healthcare organizations with the goal of optimizing quality, cost‑effective healthcare for lesbian, gay, bisexual, and transgender people.
  • Pre-Exposure Prophylaxis (PrEP) Action KitResources & Tools:
    • The PrEP Action Kit includes clinical resources to help providers incorporate PrEP into their practices. Including helpful resources such as tips on taking a comprehensive sexual history, frequently asked questions about PrEP, and a pocket card about PrEP prescribing and monitoring, this action kit is an essential resource for all providers treating LGBTQIA+ patients or patients at risk of HIV infection.

These courses are designed for doctors (CME credit provided), nurses, health professionals, and medical office staff.

Providers can view these courses on their smartphone, tablet, or computer.

We're pleased to offer these resources as we work together to deliver high-quality, equitable healthcare.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

MULTI-ALL-CDCRCM-059067-24-CPN58594

Education & TrainingCommercialMedicare AdvantageMedicaidMay 21, 2024

You are invited: Thriving, not just surviving: navigating challenging times as a clinician

Join us to hear from a diverse panel of experienced professionals from Motivo and Anthem. During this interactive webinar, we will explore the recent research on the impact mental health has on providers and share insights into support services like counseling, stress management, and self-care resources.

Register today for the Thriving Not Just Surviving: Navigating Challenging Times as a Clinician forum hosted by Anthem and Motivo for Anthem providers.

Wednesday, June 26, 2024 | 3:30 to 5 p.m. ET

Please register for this event using this link: Forum registration

Recognizing the emotional stress providers often experience, this forum aims to deepen the discussion on mental health and the importance of prioritizing clinician’s self-care.

Together, we will work to foster a culture of understanding and support not just for clients, but for providers. By doing so, we work collaboratively for the health and wellbeing of all Americans and the communities in which we live and serve.

Each forum will continue the exploration of ways we can reduce disparities in healthcare, demonstrate cultural humility, have difficult and productive conversations, learn about valuable resources, and improve the health and wellbeing of our communities.

Also, join us in November, National Family Caregivers Awareness Month, for a webinar dedicated to supporting caregivers.

We are committed to working together to achieve improved outcomes and foster genuine collaboration with our care provider partners.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCRCM-057115-24-CPN57088

Education & TrainingCommercialMedicare AdvantageMedicaidJune 1, 2024

Introducing advanced eLearning features for MyDiversePatients.com

We have enhanced functionality on the eLearning platform MyDiversePatients.com.

This new functionality identifies learners and supports our ongoing commitment to health equity and cultural competency.

When a care provider (doctor, nurse, health professional, office staff) starts an online continuing medical education (CME) course, they now have the option to register a National Provider Identifier (NPI):

  • Flexibility: Self-paced learning gives the learner the freedom to decide when and where to take the trainings.
  • Multi-device accessibility: The course site is fully responsive and designed to work with multiple devices, including smartphone, tablet, and desktop. This means you can learn from the comfort of your home, while on the go, in the office, or any location of your choosing.
  • Progress tracking: The NPI registration allows the platform to monitor and track learning progress and achievements, helping health professionals to meet their CME requirements efficiently.
  • Credit management: Upon completion of a CME course and review of the recommended materials, the user has the opportunity to fill in a certificate of completion with the information they wish to appear on the document itself.
  • Find Care provider search tool: If the eLearner chooses to register their NPI when they take a CME course, progress is tracked to completion. The NPI number allows for a cultural competency indicator to appear beside the provider’s name in directories (Find Care). This is designed to support referring practitioners and members by being able to identify providers who have received certificates in cultural competency.

Goals of My Diverse Patients:

  • Offer a comprehensive repository of resources for care providers to help support the needs of diverse patients and address disparities.
  • Provide cultural competency for relevant resources from external sources (such as, medical journals and medical/quality organizations.)

Benefits:

  • Availability of multiple free CME resources — CME courses are offered through the American Academy of Family Physicians.
  • Real life stories about diverse patients and the unique challenges they face.
  • Tips for working with diverse patients to promote improvement in health outcomes.

New courses with CME credits and nursing continuing education units will be added in 2024. We look forward to working together to deliver equitable healthcare.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCRCM-055846-24-CPN54448

Policy UpdatesMedicare AdvantageMay 10, 2024

Carelon Medical Benefits Management, Inc updates

This article was updated as of August 23, 2024.

Effective September 1, 2024, Anthem will transition to the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines for medical necessity/clinical appropriateness reviews for requested interventions. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. This does not equate to the presence of a prior authorization requirement. In the event a prior authorization requirement for these services will be implemented, a separate notice will be distributed before the addition of any prior authorization requirements.

  • Site of Care Guidelines:
    • Site of Care for Advanced Imaging
    • Rehabilitative Site of Care
    • Surgical Site of Care

Please share this notice with other members of your practice and office staff.

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CR-055352-24-CPN54514, MULTI-ALL-CDCR-066460-24

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 2, 2024

Carelon Medical Benefits Management, Inc. genetic testing code updates

Effective for dates of service on and after September 1, 2024, the following codes will require prior authorization through Carelon Medical Benefits Management, Inc.:

CPT® code

Description

81457

Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, microsatellite instability

81458

Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, copy number variants and microsatellite instability

81459

Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements

81462

Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (for example, plasma), interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants and rearrangements

81463

Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (for example, plasma), interrogation for sequence variants; DNA analysis, copy number variants, and microsatellite instability

81464

Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (for example, plasma), interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements

0420U

Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma

0422U

Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate

0423U

Psychiatry (for example, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition

0424U

Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no molecular evidence, low-, moderate- or elevated-risk of prostate cancer

0425U

Genome (for example, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (for example, parents, siblings)

0426U

Genome (for example, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis

0428U

Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutation burden

0434U

Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes

0438U

Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CYP2D6, including reported phenotypes and impacted gene-drug interactions

As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management in one of several ways:

  • Access Carelon Medical Benefits Management’s ProviderPortalSM directly at providerportal.com.
    • Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
  • Access Carelon Medical Benefits Management via the Availity website at Availity.com.

If you have questions related to guidelines, contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CR-056848-24-CPN56791

Medical Policy & Clinical GuidelinesMedicaidMay 13, 2024

Medical Policies and Clinical Utilization Management Guidelines update

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Q4 2023. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit anthem.com/ca/provider/policies/clinical-guidelines/search/.

Notes/updates

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive:

  • MED.00146 - Gene Therapy for Sickle Cell Disease:
    • Outlines the Medically Necessary and Investigational & Not Medically Necessary criteria for Gene therapy for sickle cell disease
  • RAD.00068 - Myocardial Strain Imaging:
    • Myocardial strain imaging in considered Investigational & Not Medically Necessary for all indications
  • SURG.00026 - Deep Brain, Cortical, and Cerebellar Stimulation:
    • Reformatted Position Statement and added headers
    • Reformatted Medically Necessary statements to move target treatment areas into criteria
    • Revised Medically Necessary statement for primary dystonia to remove dystonia manifestation types
    • Reformatted Medically Necessary statements for DBS for Parkinson’s, primary dystonia, and OCD
    • Reformatted Medically Necessary statements for epilepsy
    • Revised DBS for epilepsy Medically Necessary statement regarding non-epileptic seizures
    • Revised Position Statement to add revision/replacement Medically Necessary and Investigational & Not Medically Necessary statements for DBS, cortical stimulation, and battery
    • Revised and reformatted Investigational & Not Medically Necessary statements
  • SURG.00097 - Scoliosis Surgery:
    • Revision to Position Statement formatting
    • Added Medically Necessary and Investigational & Not Medically Necessary criteria for revision, replacement, or removal of vertebral body tethering to Position Statement
  • SURG.00142 - Genicular Procedures for Treatment of Knee Pain
    Previously titled: Genicular Nerve Blocks and Ablation for Chronic Knee Pain:
    • Revised title
    • Added genicular artery embolization to the scope of document
    • Revised Position Statement to add genicular artery embolization as Investigational & Not Medically Necessary
  • CG-DME-42 - Continuous Glucose Monitoring Devices:
    Previously titled: Continuous Glucose Monitoring Devices and External Insulin Infusion Pumps
    • Revised title
    • Moved content related to external insulin pumps to new document CG-DME-51 and automated insulin delivery systems to new document CG-DME-50
    • Revised existing Medically Necessary and Not Medically Necessary statements
  • CG-DME-52 - Continuous Passive Motion Devices in the Home Setting:
    • Use of a continuous passive motion (CPM) device in the home setting is considered Not Medically Necessary for all indications
  • CG-MED-94 - Vestibular Function Testing:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for vestibular function testing
  • CG-SURG-09 - Temporomandibular Disorders:
    • Revised formatting of Medically Necessary statement
    • Revised surgical procedures criteria
    • Added MIRO Therapy to Not Medically Necessary statement
  • CG-SURG-70 - Gastric Electrical Stimulation:
    • Added Medically Necessary and Not Medically Necessary criteria to Clinical Indications for removal, revision, or replacement of a gastric electrical stimulator

Medical Policies

On November 9, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect August 13, 2024.

Publish date

Medical Policy number

Medical Policy title

New or revised

1/3/2024

LAB.00026

Systems Pathology and Multimodal Artificial Intelligence Testing for Prostate Cancer

Previously titled: Systems Pathology Testing for Prostate Cancer

Revised

1/3/2024

LAB.00046

Testing for Biochemical Markers for Alzheimer’s Disease

Revised

1/3/2024

LAB.00050

Metagenomic Sequencing for Infectious Disease in the Outpatient Setting

Conversion New

1/3/2024

MED.00057

MRI Guided High Intensity Focused Ultrasound Ablation for Non-Oncologic Indications

Revised

1/18/2024

*MED.00146

Gene Therapy for Sickle Cell Disease

New

1/3/2024

*RAD.00068

Myocardial Strain Imaging

New

1/3/2024

SURG.00010

Treatments for Urinary Incontinence

Revised

12/28/2023

*SURG.00026

Deep Brain, Cortical, and Cerebellar Stimulation

Revised

12/28/2023

*SURG.00097

Scoliosis Surgery

Revised

1/3/2024

*SURG.00142

Genicular Procedures for Treatment of Knee Pain

Previously titled: Genicular Nerve Blocks and Ablation for Chronic Knee Pain

Revised

1/3/2024

TRANS.00027

Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors

Revised

Clinical UM Guidelines

On November 9, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on January 4, 2024. These guidelines take effect August 13, 2024.

Publish date

Clinical UM Guideline number

Clinical UM Guideline title

New or revised

1/3/2024

*CG-DME-42

Continuous Glucose Monitoring Devices

Previously titled: Continuous Glucose Monitoring Devices and External Insulin Infusion Pumps

Revised

1/3/2024

CG-DME-44

Electric Tumor Treatment Field (TTF)

Revised

1/3/2024

CG-DME-50

Automated Insulin Delivery Systems

Conversion New

1/3/2024

CG-DME-51

External Insulin Pumps

Conversion New

1/3/2024

*CG-DME-52

Continuous Passive Motion Devices in the Home Setting

New

1/3/2024

CG-LAB-25

Outpatient Glycated Hemoglobin and Protein Testing

Revised

1/3/2024

CG-MED-92

Foot Care Services

Revised

1/3/2024

*CG-MED-94

Vestibular Function Testing

New

1/3/2024

*CG-SURG-09

Temporomandibular Disorders

Revised

12/28/2023

*CG-SURG-70

Gastric Electrical Stimulation

Revised

1/3/2024

CG-SURG-94

Keratoprosthesis

Revised

12/28/2023

CG-SURG-95

Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention

Revised

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-056946-24-CPN56516

Medical Policy & Clinical GuidelinesMedicare AdvantageApril 26, 2024

MCG Care Guidelines 28th edition

Effective September 1, 2024, Anthem will upgrade to the 28th edition of MCG Care Guidelines for the following modules. Below is high level summary of the updates and is not intended to be all inclusive:

  • Behavioral Health Care (BHG)
    • The goal length of stay (GLOS) has been changed in 2 guidelines in the 28th edition of Behavioral Health Care.
  • Inpatient & Surgical Care (ISC)
    • The goal length of stay (GLOS) has been changed in a total of 72 Optimal Recovery Guidelines in the 28th edition of Inpatient & Surgical Care. In medical Optimal Recovery Guidelines, the GLOS has been changed in 37 guidelines and the GLOS has been changed in 35 surgical Optimal Recovery Guidelines, in the 28th edition of Inpatient & Surgical Care.
  • General Recovery Care (GRG)
    • The benchmark length of stay (BLOS) has been refined in the 28th edition of General Recovery Care.
  • Chronic Care (CCG)
    • A total of 10 guidelines have been moved in the 28th edition of Chronic Care.

For questions, please contact the provider service number on the back of the member's ID card.

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CR-056690-24-CPN55820

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 7, 2024

Clinical Criteria updates

Effective June 10, 2024

Summary: On May 19, 2023, August 18, 2023, November 17, 2023, December 11, 2023, and February 23, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits. 

Visit Clinical Criteria to search for specific policies. If you have questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

June 10, 2024

*CC-0258

iDoseTR (travoprost Implant)

New

June 10, 2024

*CC-0259

Amtagvi (lifleucel)

New

June 10, 2024

*CC-0260

Nexobrid (anacaulase-bcdb)

New

June 10, 2024

*CC-0199

Empaveli (pegcetacoplan)

Revised

June 10, 2024

*CC-0041

Complement Inhibitors

Revised

June 10, 2024

CC-0128

Tecentriq (atezolizumab)

Revised

June 10, 2024

CC-0116

Bendamustine agents

Revised

June 10, 2024

CC-0161

Sarclisa (isatuximab-irfc)

Revised

June 10, 2024

CC-0158

Enhertu (fam-trastuzumab deruxtecan-nxki)

Revised

June 10, 2024

CC-0157

Padcev (enfortumab vedotin)

Revised

June 10, 2024

CC-0230

Adstiladrin (nadofaragene firadenovec-vncg)

Revised

June 10, 2024

*CC-0125

Opdivo (nivolumab)

Revised

June 10, 2024

*CC-0119

Yervoy (ipilimumab)

Revised

June 10, 2024

*CC-0099

Abraxane (paclitaxel, protein bound)

Revised

June 10, 2024

*CC-0093

Docetaxel (Taxotere)

Revised

June 10, 2024

*CC-0094

Pemetrexed (Alimta, Pemfexy, Pemrydi)

Revised

June 10, 2024

CC-0130

Imfinzi (durvalumab)

Revised

June 10, 2024

*CC-0088

Elzonris (tagraxofusp-erzs)

Revised

June 10, 2024

*CC-0118

Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin)

Revised

June 10, 2024

*CC-0112

Xofigo (Radium Ra 223 Dichloride)

Revised

June 10, 2024

*CC-0123

Cyramza (ramucirumab)

Revised

June 10, 2024

*CC-0131

Besponsa (inotuzumab ozogamicin)

Revised

June 10, 2024

CC-0121

Gazyva (obinutuzumab)

Revised

June 10, 2024

CC-0122

Arzerra (ofatumumab)

Revised

June 10, 2024

CC-0232

Lunsumio (mosunetuzumab-axgb)

Revised

June 10, 2024

CC-0109

Zaltrap (ziv-aflibercept)

Revised

June 10, 2024

CC-0135

Melanoma Vaccines

Revised

June 10, 2024

*CC-0096

Asparagine Specific Enzymes

Revised

June 10, 2024

CC-0120

Kyprolis (carfilzomib)

Revised

June 10, 2024

*CC-0117

Empliciti (elotuzumab)

Revised

June 10, 2024

*CC-0126

Blincyto (blinatumomab)

Revised

June 10, 2024

CC-0113

Sylvant (siltuximab)

Revised

June 10, 2024

CC-0132

Mylotarg (gemtuzumab ozogamicin)

Revised

June 10, 2024

CC-0097

Vidaza (azacitidine)

Revised

June 10, 2024

CC-0129

Bavencio (avelumab)

Revised

June 10, 2024

*CC-0090

Ixempra (ixabepilone)

Revised

June 10, 2024

CC-0110

Perjeta (pertuzumab)

Revised

June 10, 2024

*CC-0115

Kadcyla (ado-trastuzumab)

Revised

June 10, 2024

*CC-0108

Halaven (eribulin)

Revised

June 10, 2024

CC-0089

Mozobil (plerixafor)

Revised

June 10, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

June 10, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

June 10, 2024

*CC-0212

Tezspire (tezepelumab-ekko)

Revised

June 10, 2024

*CC-0033

Xolair (omalizumab)

Revised

June 10, 2024

*CC-0043

Monoclonal Antibodies to Interleukin-5

Revised

June 10, 2024

*CC-0029

Dupixent (dupilumab)

Revised

June 10, 2024

*CC-0208

Adbry (tralokinumab)

Revised

June 10, 2024

*CC-0062

Tumor Necrosis Factor Antagonists

Revised

June 10, 2024

*CC-0067

Prostacyclin Infusion and Inhalation Therapy

Revised

June 10, 2024

*CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

June 10, 2024

*CC-0064

Interleukin-1 Inhibitors

Revised

June 10, 2024

*CC-0057

Krystexxa (pegloticase)

Revised

June 10, 2024

*CC-0068

Growth Hormones

Revised

June 10, 2024

*CC-0047

Trogarzo

Revised

June 10, 2024

*CC-0078

Orencia (abatacept)

Revised

June 10, 2024

*CC-0107

Bevacizumab for Non-ophthalmologic Indications

Revised

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CR-058762-24-CPN57659

PharmacyMedicare AdvantageJune 1, 2024

Addressing medication adherence gaps

Medications are the primary intervention in treating and preventing disease. For most conditions, medications need to be taken 80% or more of the time to see an improvement in clinical outcomes.

Forty to fifty percent of patients are non-adherent to their medications for chronic conditions, leading to 100,000 preventable deaths and $100 to $300 billion in preventable medical costs per year.*

How can we prevent and close adherence gaps?

Be aware of contributing factors that influence non-adherence:

  • Cognitive impairment
  • Fear of side effects
  • Too many medications
  • History of non-adherence
  • Lack of perceived benefit
  • Confusion
  • Transportation
  • Cost

Implement a standardized process to identify patients with non-adherence:

  • Ask about adherence at every appointment.
  • Incorporate patient questionnaires or patient interviews using open-ended questions into existing workflows.
  • Analyze non-adherence reporting or claims to identify patients.
  • Leverage your electronic health record to identify patients at risk for non-adherence.

Be proactive: Tailor the solution to the patient’s needs or concerns:

  • Simplify the medication regimen by considering once daily dosing.
  • Always educate patients on benefits and risks of taking or not taking their medications.
  • Leverage real-time prescription benefit to select lower cost and formulary medications during the electronic prescribing process.
  • Consider home delivery (mail) and 90-day supply to prevent refill gaps, avoid long waits at the pharmacy, and minimize transportation barriers.

Consider medication non-adherence first as a reason when a patient’s condition is not under control.

*Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018; 22:18-033. doi: 10.7812/TPP/18-033. PMID: 30005722; PMCID: PMC6045499.
Gooptu A, Taitel M, Laiteerapong N, Press VG. Association between Medication Non-Adherence and Increases in Hypertension and Type 2 Diabetes Medications. Healthcare (Basel). July 31, 2021; 9(8): 976. doi: https://doi.org/10.3390/healthcare9080976.
Brown M, Sinsky CA. Medication Adherence. Improve Patient Outcomes and Reduce Costs. American Medical Association Steps Forward. June 5, 2015. https://edhub.ama-assn.org/steps-forward/module/2702595. Accessed May 16, 2023.
Eight reasons patients don’t take their medications. American Medication Association. Feb 22, 2023. Accessed May 17, 2023.
https://ama-assn.org/delivering-care/patient-support-advocacy/8-reasons-patients-dont-take-their-medications.
El Halabi J, Minteer W, Boehmer KR. Identifying and Managing Treatment Nonadherence. Medical Clinics of North America. 2022; 106(4): 615-626. doi: https://doi.org/10.1016/j.mcna.2022.02.003.
Kini V, Ho PM. Interventions to Improve Medication Adherence. JAMA. 2018; 320(23): 2461. doi: https://doi.org/10.1001/jama.2018.19271.

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CR-058770-24-CPN58567

PharmacyCommercialJune 1, 2024

Pharmacy information available on our provider website

Visit the Drug Lists page on our website at anthem.com/ms/pharmacyinformation/home.html for more information about:

  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug lists and changes.
  • Prior authorization criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits.

Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access.

Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CM-058760-24-CPN58712

PharmacyMedicare AdvantageJune 1, 2024

Improving patient outcomes with statin therapy in diabetes

Cardiovascular disease is the leading cause of death among people with diabetes. 1 National guidelines continue to recommend statin therapy in all patients with diabetes between the ages of 40 and 75, regardless of low-density lipoprotein (LDL) level, to prevent development of cardiovascular disease:

  • Reducing LDL-C levels by ~39 mg/dL with statin therapy can reduce heart disease and stroke mortality by 13%, regardless of the baseline LDL cholesterol levels.1
  • Nearly 60% of statin-eligible patients were never offered statin therapy by their doctor.2 Moreover, 50% of adults in the United States who would benefit from statins are taking them.3
  • Up to 34% of patients never fill the initial statin prescription (primary non-adherence).4

Statin Use in Patients with Diabetes (SUPD) is a CMS-adopted quality Star measure:

  • The SUPD measure is defined as percent of Medicare Part D beneficiaries 40 to 75 years old who were dispensed at least two diabetes medication fills and received a statin medication fill during the measurement period.
  • When assessing patients for appropriateness of statin therapy, also evaluate for potential measure exclusions.

Exclusions for the SUPD measure include:

  • End stage renal disease.
  • Hospice.
  • Rhabdomyolysis or myopathy.
  • Pregnancy/lactation.
  • Cirrhosis.
  • Pre-diabetes.
  • Polycystic ovary syndrome.
  • Fertility medication.

    • Reassess patient every year to evaluate the appropriateness of acceptable exclusions.
    • Exclusions require a submitted code each calendar year.

Best practices in initiating and improving statin adherence:

  • Offer statin therapy to all patients ages 40 to 75 years old who have diabetes, regardless of LDL.
  • Guidelines recommend moderate or high intensity statin depending on additional risks.
  • Get patient buy-in: Ask patients what they know about statins. Address any fears or concerns and educate them on statin benefits:
    • Fear of and perceived side effects are the most common reasons for declining or discontinuing statin therapy.4
  • Once a statin has been prescribed, follow up with patients to assess adherence.
  • Be aware of best practices to evaluate patient reported muscle side effects and an implementation strategy for re-initiation.

View a video about statins here.

References:

  1. American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S179–S218
  2. Bradley CK, Wang TY, Li S, et al. PatientReported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019;8(7). doi: https://doi.org/10.1161/jaha.118.011765
  3. Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–991. DOI: http://dx.doi.org/10.15585/mmwr.mm6735a4
  4. 2 Tarn DM, Barrientos M, Pletcher MJ, et al. Perceptions of Patients with Primary Nonadherence to Statin Medications. The Journal of the American Board of Family Medicine. 2021;34(1):123-131. doi: https://doi.org/10.3122/jabfm.2021.01.200262
  5. CDC. Statins and Diabetes: What You Should Know. Centers for Disease Control and Prevention. Published January 30, 2023. cdc.gov/diabetes/library/features/Statins_Diabetes.html
  6. Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125
  7. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11). doi: https://doi.org/10.1161/cir.0000000000000678
  8. Collins R, Reith C, Emberson J, et al. The Lancet. 2016;388(10059):2532-2561. Interpretation of the evidence for the efficacy and safety of statin therapy. doi: https://doi.org/10.1016/s0140-6736(16)31357-5
  9. Hla D, Jones R, Blumenthal RS, et al. Assessing severity of statin side effects: Fact vs fiction. American College of Cardiology. April 09, 2018. Accessed May 17, 2023. acc.org/latest-in-cardiology/articles/2018/04/09/13/25/assessing-severity-of-statin-side-effects
  10. Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease. Annals of Internal Medicine. 2020;173(10):806-812. doi: https://doi.org/10.7326/m20-4680

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CR-056670-24-CPN55983

Quality ManagementCommercialMay 6, 2024

Enhance patient access to digital health resources

Use this guide to help your patients better understand and use online health resources.

The anthem.com/provider portal and Provider News Quality Management page contains training opportunities, resources, updates, pharmacy and behavioral health information, forms, and policies, and Availity information for billing.

Refer to attachment to view full details

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CM-054704-24-CPN54223

ATTACHMENTS (available on web): Enhance patient access to digital health resources (pdf - 0.42mb)

Quality ManagementMedicaidJune 1, 2024

Important information about utilization management

Our utilization management (UM) decisions are based on the appropriateness of care and service needed as well as the member’s coverage according to their health plan. We do not reward care providers or other individuals for issuing denials of coverage, service, or care. We do not make decisions about hiring, promoting, or terminating these individuals based on the idea or thought that they will deny benefits. In addition, we do not offer financial incentives for UM decision makers to encourage decisions resulting in underutilization. Our Medical Policies are available on our provider website at providers.anthem.com/ca > Resources > Medical Policies and Clinical UM Guidelines.

You can request a free copy of our UM criteria from our Medical Management department. Care providers can discuss a UM denial decision with a physician reviewer by calling us toll free at 888-831-2246, option 4. To access UM criteria online, go to providers.anthem.com/ca > Resources > Medical Policies and Clinical UM Guidelines.

We are staffed with clinical professionals who work with you to coordinate our members’ care. Our staff will identify themselves by name, title, and organization name when initiating or returning calls regarding UM issues.

You can submit precertification requests 24/7 by:

  • Calling: 888-831-2246, option 3 (includes both inside and outside L.A. County).
  • Faxing a Pre-Service Review form to 800-754-4708 (includes both inside and outside L.A. County).

Have questions about utilization management?

Call one of our Medi-Cal Customer Care Centers Monday through Friday, from 7 a.m. to 7 p.m., at 800-407-4627 (TTY 711) (outside L.A. County) or 888-285-7801 (TTY 711) (inside L.A. County).

We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-055826-24-SRS55413

Quality ManagementMedicaidJune 1, 2024

Members’ Rights and Responsibilities section

In line with our commitment to participating practitioners and members, Anthem has a Members’ Rights and Responsibilities section located within the provider manual. The delivery of quality healthcare requires cooperation between patients, their care providers, and their healthcare benefit plans. One of the first steps is for patients and care providers to understand their rights and responsibilities. Review this section in your provider manual at providers.anthem.com/ca > Resources > Provider Manuals, Policies & Guidelines.

Beyond simply signing a contract, care providers are part of a genuine collaboration aimed at improving the lives of real people.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-055823-24-SRS55413

Quality ManagementMedicaidJune 1, 2024

Complex Case Management program

Managing illness can be a daunting task for our members. It is not always easy to understand test results, know how to obtain essential resources for treatment, or know who to contact with questions and concerns.

Anthem offers a Complex Case Management program to help make healthcare easier and less overwhelming for our members. Our care managers are part of an interdisciplinary team of clinicians and other resource professionals working to support members and their caregivers to stay connected with their care team and follow their treatment plan. Care managers educate and empower our members to participate in their own care. The goal is to help members understand their illnesses and learn about care choices to ensure they have access to quality, efficient healthcare. Care managers also support members and their caregivers with transitions between care settings.

Members or their caregivers can request case management by calling the Member Services number located on the back of their ID card.

Physicians can refer their patients by submitting a Case Management Referral Form via fax or email.

Have questions about case management?

Call one of our Medi-Cal Customer Care Centers Monday through Friday, from 7 a.m. to 7 p.m., at 800-407-4627 (TTY 711) (outside L.A. County) or 888-285-7801 (TTY 711) (inside L.A. County). 

We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-055413-24-SRS55413

Quality ManagementCommercialApril 19, 2024

Improving patient health and digital literacies

Taking the time to help your patients boost their health and digital literacies can enhance trust and can lead to improved health outcomes and patient experience.

Refer to attachment to view full details

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CM-054703-24-CPN54222

ATTACHMENTS (available on web): Improving patient health and digital literacies (pdf - 0.47mb)

Quality ManagementCommercialMedicaidApril 23, 2024

Tips to Improve Adolescent Immunization (IMA) Rates

Vaccines are important in reducing the incidence of morbidity and mortality due to serious preventable diseases. Except for the annual flu and COVID vaccines, most childhood vaccines are administered before six years of age. Once children enter their pre-teen years, it is time for them to get a few more vaccines. The Center for Disease Control (CDC) and the American Academy of Pediatrics recommend pre-teens 11 and 12 years old get three vaccines to prevent diseases: 1) tetanus, diphtheria, and pertussis (Tdap); 2) meningococcal disease; and, 3) cancers caused by the human papillomavirus (HPV).

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
1 Nandi, Arindam and Anita Shet. “Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination.” Human Vaccines and Immunotherapeutics. 220; 16(8): 1900-1904. tinyurl.com/3wshrt62.
2 Reference: Ventola, C. Lee. “Immunization in the United States: Recommendations, Barriers, and Measures to Improve Compliance.” Pharmacy and Therapeutics. 2016 Jul; 41(7): 426-436. tinyurl.com/4m7s2tcc 1/30/2024.

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCM-051204-24-CPN50915

ATTACHMENTS (available on web): Tips to Improve Adolescent Immunization (IMA) Rates (pdf - 0.24mb)

Quality ManagementCommercialMedicare AdvantageApril 22, 2024

Statin Use in Persons with Cardiovascular Disease (SPC) measure exclusion criteria: HEDIS® 2024 measurement year

Measure details

Eligibility criteria:

Numerator

Males 21 to 75 years of age and females 40 to 75 years of age as of December 31, 2024, who were dispensed at least one high- or moderate-intensity statin medication during 2024.

Denominator

Males 21 to 75 years of age and females 40 to 75 years of age as of December 31, 2024, who have been diagnosed with clinical atherosclerotic cardiovascular disease (ASCVD) during 2024.

Did you know?

Certain adverse reactions to a statin medication may exclude the patient from the measure denominator if properly documented. See required exclusions below.

Required exclusions:

  • Diagnosis of myalgia, myositis, myopathy, or rhabdomyolysis during 2024:
    • Important note: The above exclusionary diagnoses must be documented each year. A diagnosis from a prior year will not carry over to the current year. These exclusionary diagnoses can come from claims or medical record data. Medical record documentation must contain two patient identifiers.
  • Diagnosis of pregnancy during 2024
  • Diagnosis of in-vitro fertilization in 2023 or 2024
  • Dispensed at least one prescription for clomiphene during 2023 or 2024
  • 66 years of age and older who are enrolled in an Institutional Special Needs Plan (I-SNP) or living long term in an institution during 2024
  • 66 years of age and older with advanced illness during 2023 and/or 2024 and frailty during 2024
  • 66 years of age and older with advanced illness during 2023 and/or 2024 and dispensed dementia medication during 2024:
    • Note: Exclusions for advanced illness, frailty, and dispensed dementia medications must come from claims.
    • The advanced illness exclusion can include telephone visits, e-visits, and virtual check-ins to meet the two visits with an advanced illness diagnosis criterion.
  • Diagnosis of end-stage renal disease (ESRD) or dialysis during 2023 or 2024
  • Diagnosis of cirrhosis during 2023 or 2024
  • Hospice and palliative care:
    • Death

Closing the gap

Documentation needed:

  • Only dispensed medication on a pharmacy claim is used to identify and close this gap.
  • Patient must use their member ID card when filling a statin prescription at the pharmacy.
  • Exclusions for advanced illness, frailty, and dispensed dementia medications must come from claims.
  • Exclusions for myalgia, myositis, myopathy, or rhabdomyolysis can come from claims or medical record data. Medical record documentation must include two patient identifiers.

Moderate- to high-intensity statin medications

Description

Prescription

High-intensity statin therapy

Atorvastatin 40 to 80 mg

Amlodipine-atorvastatin 40 to 80 mg

Rosuvastatin 20 to 40 mg

Simvastatin 80 mg

Ezetimibe-simvastatin 80 mg

Moderate-intensity statin therapy

Atorvastatin 10 to 20 mg

Amlodipine-atorvastatin 10 to 20 mg

Rosuvastatin 5 to 10 mg

Simvastatin 20 to 40 mg

Ezetimibe-simvastatin 20 to 40 mg

Pravastatin 40 to 80 mg

Lovastatin 40 mg

Fluvastatin 40 to 80 mg

Pitavastatin 1 to 4 mg

Best practices

Prescribe low-cost generics to eliminate cost as a barrier:

  • Atorvastatin, lovastatin, pravastatin, simvastatin, and rosuvastatin are available for $0 for extended days’ supply prescriptions. These medications are free using the Medicare Advantage prescription drug plan benefit for Anthem even if the patient reaches the coverage gap.
  • Encourage patients to fill their statin medication at a preferred pharmacy using their benefit.
  • Discourage the use of discount cards.
  • Let Anthem know of any patients filling outside of the benefit. Anthem can reach out to the pharmacy and/or patient regarding the $0 benefit cost.
  • Short trial fills of a statin medication with $0 cost may help hesitant patients be more willing to try or re-try a statin medication.

Help patients manage potential side effects:

  • Educate patients about the long-term cardiovascular benefits and potential side effects of a statin medication.
  • If a patient experienced statin intolerance previously, a trial of a lower dose or different statin medication may help reduce risk or side effects.

Note: Patient history of statin-induced myalgia, myositis, myopathy, or rhabdomyolysis in a prior year must be documented each year for patient to be excluded from this measure. A diagnosis from a prior year will not carry over to the current year.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CRCM-055708-24-CPN55314

Quality ManagementCommercialMedicare AdvantageMedicaidJune 1, 2024

New resources to improve your HEDIS® and CAHPS® quality rates

The Provider Quality and Health Equity team at Anthem has been hard at work creating and identifying resources to help improve quality rates and the overall experiences of your patients. Be sure to check the Quality Management section of this Provider Newsletter site periodically for resources and new content, including provider toolkits and HEDIS-related materials to help optimize your quality rates. New content, resources, webinars, and training opportunities are also available on the Clinical Quality Webinars Hub. Mydiversepatients.com is a great resource for training and resources to help you learn about and serve your diverse population.

We are committed to finding solutions that help our care provider partners offer high quality services to our members.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County.

CABC-CDCRCM-052866-24-CPN50908